Form 8-K Krystal Biotech, Inc. For: Feb 26
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St rebounds after Fed's first rate hike in years as oil, Treasury yields dip
- Oil falls 1% as investors watch Middle East supply disruptionsÂ
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Evercore ISI Removes Krystal Biotech (KRYS) From Tactical Outperform List
February 26, 2024 11:26 AM ESTEvercore ISI analyst Josh Schimmer reiterated an Outperform rating and $168.00 price target on Krystal Biotech (NASDAQ: KRYS)
Removes from Tactical Outperform List.For an analyst ratings summary and ratings history on Krystal Biotech... More
